New drug cocktail aims to shrink rare bladder cancer before surgery
NCT ID NCT07412171
First seen Feb 18, 2026 · Last updated May 11, 2026 · Updated 7 times
Summary
This study tests whether giving two drugs (toripalimab and 9MW2821) before surgery can improve outcomes for people with a rare cancer of the upper urinary tract. About 40 adults with localized disease will be randomly assigned to either the drug combo followed by surgery, or surgery alone. The main goal is to see if the drugs can make the cancer disappear completely by the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER TRACT UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.